Immune system disorders, such as Graves' disease or lupus, are also linked to vitamin B12 deficiency
The cardiovascular safety profile makes GLP-1 medications particularly attractive for people with diabetes who also have heart disease risk factors
These results provide important insights into the nutritional and functional properties of the products, particularly in the context of vegan athletic performance, where adequate protein intake is critical for muscle maintenance and development
These include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GIP/GLP-1 receptor agonist
REMODEL: a mechanistic trial evaluating the effects of semaglutide on the kidneys in people with type 2 diabetes and chronic kidney disease